118 related articles for article (PubMed ID: 15381827)
1. Antithrombotic effect of L-arginine in hypertensive rats.
Cylwik D; Mogielnicki A; Kramkowski K; Stokowski J; Buczko W
J Physiol Pharmacol; 2004 Sep; 55(3):563-74. PubMed ID: 15381827
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic activity of losartan in two kidney, one clip hypertensive rats. A study on the mechanism of action.
Chabielska E; Pawlak R; Wollny T; Rółkowski R; Buczko W
J Physiol Pharmacol; 1999 Mar; 50(1):99-109. PubMed ID: 10210158
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic effect of captopril and enalapril in young rats.
Buczko W; Kubik A; Kucharewicz I; Chabielska E
Pol J Pharmacol; 2004; 56(1):97-104. PubMed ID: 15047983
[TBL] [Abstract][Full Text] [Related]
4. Propranolol prevents the development of venous thrombosis in rats by a platelet-dependent mechanism.
Gruszecki M; Rółkowski R; Pawlak R; Buczko W
Pol J Pharmacol; 2001; 53(1):5-10. PubMed ID: 11785911
[TBL] [Abstract][Full Text] [Related]
5. Aliskiren inhibits experimental venous thrombosis in two-kidney one- clip hypertensive rats.
Hermanowicz JM; Hermanowicz A; Buczko P; Leszczynska A; Tankiewicz-Kwedlo A; Mogielnicki A; Buczko W
Thromb Res; 2013 Jan; 131(1):e39-44. PubMed ID: 23174623
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic effect of tissue and plasma type angiotensin converting enzyme inhibitors in experimental thrombosis in rats.
Wojewódzka-Zelezniakowicz M; Chabielska E; Mogielnicki A; Kramkowski K; Karp A; Opadczuk A; Domaniewski T; Malinowska-Zaprzałka M; Buczko W
J Physiol Pharmacol; 2006 Jun; 57(2):231-45. PubMed ID: 16845228
[TBL] [Abstract][Full Text] [Related]
8. The involvement of AT(2)-receptor in the antithrombotic effect of losartan in renal hypertensive rats.
Chabielska E; Matys T; Kucharewicz I; Pawlak D; Rólkowski R; Buczko W
J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):263-7. PubMed ID: 11881035
[TBL] [Abstract][Full Text] [Related]
9. Effect of endothelin-1 on some hemostatic parameters in normotensive rats.
Pietraszek M; Chabielska E; Azzadin A; Pawlak R; Buczko W
Acta Physiol Hung; 1996; 84(3):329-30. PubMed ID: 9219627
[TBL] [Abstract][Full Text] [Related]
10. Dual effects of sulfated D-galactans from the red algae Botryocladia occidentalis preventing thrombosis and inducing platelet aggregation.
Farias WR; Nazareth RA; Mourão PA
Thromb Haemost; 2001 Dec; 86(6):1540-6. PubMed ID: 11776325
[TBL] [Abstract][Full Text] [Related]
11. The effect of L-arginine on the progression of chronic renal scarring in remnant kidney.
Liu B; Haylor J; El Nahas AM
Chin Med J (Engl); 2002 Feb; 115(2):197-201. PubMed ID: 11940330
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in rats.
Schumacher WA; Seiler SE; Steinbacher TE; Stewart AB; Bostwick JS; Hartl KS; Liu EC; Ogletree ML
Eur J Pharmacol; 2007 Sep; 570(1-3):167-74. PubMed ID: 17597608
[TBL] [Abstract][Full Text] [Related]
13. The effect of taurolidine on experimental thrombus formation.
Kaptanoglu L; Kucuk HF; Colak E; Kurt N; Bingul SM; Akyol H; Torlak OA; Yazici F
Eur J Pharmacol; 2008 Jan; 578(2-3):238-41. PubMed ID: 17961549
[TBL] [Abstract][Full Text] [Related]
14. Losartan inhibits experimental venous thrombosis in spontaneously hypertensive rats.
Chabielska E; Pawlak R; Golatowski J; Rółkowski R; Pawlak D; Buczko W
Thromb Res; 1998 Jun; 90(6):271-8. PubMed ID: 9700857
[TBL] [Abstract][Full Text] [Related]
15. [Antithrombotic and antiplatelet effects of rosmarinic acid, a water-soluble component isolated from radix Salviae miltiorrhizae (danshen)].
Zou ZW; Xu LN; Tian JY
Yao Xue Xue Bao; 1993; 28(4):241-5. PubMed ID: 8213164
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosis.
Hennan JK; Elokdah H; Leal M; Ji A; Friedrichs GS; Morgan GA; Swillo RE; Antrilli TM; Hreha A; Crandall DL
J Pharmacol Exp Ther; 2005 Aug; 314(2):710-6. PubMed ID: 15860572
[TBL] [Abstract][Full Text] [Related]
17. Chronic exogenous hyperinsulinaemia-induced hypertension in pregnant rats: effect of chronic treatment with l-arginine.
Podjarny E; Bursztyn M; Rashed G; Benchetrit S; Katz B; Green J; Karmeli F; Peleg E; Bernheim J
Clin Sci (Lond); 2001 Jun; 100(6):667-71. PubMed ID: 11352784
[TBL] [Abstract][Full Text] [Related]
18. Losartan metabolite EXP3174 reduces the weight of formed thrombus in 2K1C hypertensive rats.
Gromotowicz-Poplawska A; Nazarko-Sadowska J; Chabielska E
J Physiol Pharmacol; 2019 Jun; 70(3):. PubMed ID: 31566190
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic effects due to pharmacological modulation of thrombin-activatable fibrinolysis inhibitor in rats.
Soni H; Sharma A; Bhatt S; Jain MR; Patel PR
Pharmacology; 2008; 82(4):304-9. PubMed ID: 18936552
[TBL] [Abstract][Full Text] [Related]
20. Aqueous extracts of Ocimum basilicum L. (sweet basil) decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio--venous shunt thrombosis in vivo.
Tohti I; Tursun M; Umar A; Turdi S; Imin H; Moore N
Thromb Res; 2006; 118(6):733-9. PubMed ID: 16469363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
